⌘K

Home/Filings/4/0000899866-21-000050

4//SEC Filing

ORLOFF JOHN J 4

Accession 0000899866-21-000050

CIK 0000899866other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:53 PM ET

Size

4.8 KB

Accession

0000899866-21-000050

Insider Transaction Report

Form 4

Period: 2021-06-08

ALEXION PHARMACEUTICALS, INC.ALXN

EVP, Research & Development

Transactions

Tax Payment
Common Stock, par value $.0001 per share
2021-06-08$177.00/sh−1,957$346,389→ 86,367 total

Footnotes (1)

[F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.

Documents

1 file

4
wf-form4_162327201970263.xmlPrimary
FORM 4

Issuer

ALEXION PHARMACEUTICALS, INC.

CIK 0000899866

Entity typeother

Related Parties

1

filerCIK 0001643941

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 4:53 PM ET
Size: 4.8 KB

View on SEC.gov